These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37826949)

  • 1. Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
    Han Q; Yan X; Wang L; Zhang N; Zhang W; Li H; Chen W; You H; Yang A
    Biochem Biophys Res Commun; 2023 Nov; 682():259-265. PubMed ID: 37826949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
    Liu J; Lu YF; Zhang Y; Wu KC; Fan F; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):816-24. PubMed ID: 23948738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
    Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
    Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
    J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of patent ductus venosus on bile acid homeostasis in aryl hydrocarbon receptor (AhR)-null mice.
    Csanaky IL; Lickteig AJ; Zhang Y; Klaassen CD
    Toxicol Appl Pharmacol; 2020 Sep; 403():115136. PubMed ID: 32679164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin improves cholestatic liver disease via the gut-liver axis.
    Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
    J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice.
    Ozeki J; Uno S; Ogura M; Choi M; Maeda T; Sakurai K; Matsuo S; Amano S; Nebert DW; Makishima M
    Toxicology; 2011 Feb; 280(1-2):10-7. PubMed ID: 21095216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl hydrocarbon receptor (AhR) mediated short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on bile acid homeostasis in mice.
    Csanaky IL; Lickteig AJ; Klaassen CD
    Toxicol Appl Pharmacol; 2018 Mar; 343():48-61. PubMed ID: 29452137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4.
    Gao X; Xie C; Wang Y; Luo Y; Yagai T; Sun D; Qin X; Krausz KW; Gonzalez FJ
    Biochem Pharmacol; 2016 Nov; 119():93-104. PubMed ID: 27569425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
    Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
    Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Vps33b deficiency aggravates cholic acid-induced cholestatic liver injury in male mice.
    Fu KL; Chen P; Zhou YY; Jiang YM; Gao Y; Zhang HZ; Guan LH; Wang CH; Liu JL; Huang M; Bi HC
    Acta Pharmacol Sin; 2022 Apr; 43(4):933-940. PubMed ID: 34253877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.
    Yang Q; Yang F; Tang X; Ding L; Xu Y; Xiong Y; Wang Z; Yang L
    BMC Complement Altern Med; 2015 Apr; 15():122. PubMed ID: 25887351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
    Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
    J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
    Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
    FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
    Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
    J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.